Enanta Pharmaceuticals Inc (ENTA)
12.48
-0.44
(-3.41%)
USD |
NASDAQ |
Apr 25, 16:00
12.48
0.00 (0.00%)
After-Hours: 16:42
Enanta Pharmaceuticals Accounts Payable (Quarterly): 9.326M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.326M |
September 30, 2023 | 4.097M |
June 30, 2023 | 7.932M |
March 31, 2023 | 11.76M |
December 31, 2022 | 4.352M |
September 30, 2022 | 6.00M |
June 30, 2022 | 1.245M |
March 31, 2022 | 5.985M |
December 31, 2021 | 7.841M |
September 30, 2021 | 9.54M |
June 30, 2021 | 5.895M |
March 31, 2021 | 5.699M |
December 31, 2020 | 6.305M |
September 30, 2020 | 5.737M |
June 30, 2020 | 6.074M |
March 31, 2020 | 5.945M |
December 31, 2019 | 6.596M |
September 30, 2019 | 6.689M |
June 30, 2019 | 6.504M |
March 31, 2019 | 8.884M |
December 31, 2018 | 5.622M |
September 30, 2018 | 4.745M |
June 30, 2018 | 4.902M |
March 31, 2018 | 4.696M |
Date | Value |
---|---|
December 31, 2017 | 3.268M |
September 30, 2017 | 3.714M |
June 30, 2017 | 5.488M |
March 31, 2017 | 4.056M |
December 31, 2016 | 1.952M |
September 30, 2016 | 3.377M |
June 30, 2016 | 2.044M |
March 31, 2016 | 2.572M |
December 31, 2015 | 2.767M |
September 30, 2015 | 1.543M |
June 30, 2015 | 1.614M |
March 31, 2015 | 2.343M |
December 31, 2014 | 0.567M |
September 30, 2014 | 1.874M |
June 30, 2014 | 1.284M |
March 31, 2014 | 2.041M |
December 31, 2013 | 0.84M |
September 30, 2013 | 1.481M |
June 30, 2013 | 0.918M |
March 31, 2013 | 2.371M |
December 31, 2012 | 1.774M |
September 30, 2012 | 1.851M |
June 30, 2012 | 0.833M |
September 30, 2011 | 0.566M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.245M
Minimum
Jun 2022
11.76M
Maximum
Mar 2023
6.501M
Average
6.074M
Median
Jun 2020
Accounts Payable (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 28.04M |
Galectin Therapeutics Inc | 6.431M |
Viking Therapeutics Inc | 7.512M |
Akero Therapeutics Inc | 7.038M |
89bio Inc | 8.585M |